The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing primary percutaneous intervention and receiving abciximab

BACKGROUND: Our study compared the effect of P2Y12 receptor inhibitors in combination with abciximab on clinical outcomes in patients with acute coronary syndrome (ACS). METHODS: Our study is retrospective, consisting of 852 consecutive ACS patients who presented to our clinic between 2015 and 2021,...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Onur Altınkaya, Selim Aydemir, Murat Özmen, Sidar Şiyar Aydın, Emrah Aksakal, Mustafa Özkoç, Rauf Macit, İbrahim Saraç, Yavuzer Koza, Muhammet Hakan Taş
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Via Medica 2025-10-01
Serie:	Cardiology Journal
Soggetti:	acute coronary syndrome P2Y12 receptor inhibitors glycoprotein IIB/IIIA inhibitors abciximab bleeding mortality
Accesso online:	https://journals.viamedica.pl/cardiology_journal/article/view/104531
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!